The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
Open accessAbstract
Background Intensive treatment of multiple cardiovascular risk factors can halve mortality among people with established type 2 diabetes. We investigated the effect of early multifactorial treatment after diagnosis by screening.Methods In a pragmatic, cluster-randomised, parallel-group trial done in Denmark, the Netherlands, and the UK, 343 general practices were randomly assigned screening of registered patients aged 40-69 years without known diabetes followed by routine care of diabetes or screening followed by intensive treatment of multiple risk factors. The primary endpoint was first cardiovascular event, including cardiovascular mortality and morbidity, revascularisation, and non-traumatic amputation within 5 years. Patients and staff assessing outcomes were unaware of the practice's study group assignment. Analysis was done by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00237549.Findings Primary endpoint data were available for 3055 (99·9%) of 3057 screen-detected patients. The mean age was 60·3 (SD 6·9) years and the mean duration of follow-up was 5·3 (SD 1·6) years. Improvements in cardiovascular risk factors (HbA(1c) and cholesterol concentrations and blood pressure) were slightly but significantly better in the intensive treatment group. The incidence of first cardiovascular event was 7·2% (13·5 per 1000 person-years) in the intensive treatment group and 8·5% (15·9 per 1000 person-years) in the routine care group (hazard ratio 0·83, 95% CI 0·65-1·05), and of all-cause mortality 6·2% (11·6 per 1000 person-years) and 6·7% (12·5 per 1000 person-years; 0·91, 0·69-1·21), respectively.Interpretation An intervention to promote early intensive management of patients with type 2 diabetes was associated with a small, non-significant reduction in the incidence of cardiovascular events and death.Funding National Health Service Denmark, Danish Council for Strategic Research, Danish Research Foundation for General Practice, Danish Centre for Evaluation and Health Technology Assessment, Danish National Board of Health, Danish Medical Research Council, Aarhus University Research Foundation, Wellcome Trust, UK Medical Research Council, UK NIHR Health Technology Assessment Programme, UK National Health Service R&D, UK National Institute for Health Research, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, Novo Nordisk, Astra, Pfizer, GlaxoSmithKline, Servier, HemoCue, Merck.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ADDITION (Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care) trial showed that microvascular or macrovascular events were not significantly reduced after 5 or 10 years (17% and 13% reduction, respectively), while intervention only slightly improved HbA1c.364,365”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [365]
Experimental — accuracy not yet measuredIn the citing paper
“These positive effects were not observed in the clinical intervention trials of intensified, multifactorial treatment for T2DM in primary care and early in the disease trajectory.”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [365]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Research works printed but not linked: 2
- Rutten, 1999, Dutch College of General Practitioners. Practice guideline diabetes mellitus type 2, Huisarts Wetensch, 42, 67
- Rutten, 2006, Dutch Guidelines on Type 2 Diabetes Mellitus. Dutch College of General Practitioners, Huisarts Wetensch, 49, 137
Cited by
Sorted by citations
Items 401–462 of 462
Screening for type 2 diabetes and population mortality over 10 years
Lauritzen, T., & Borch‐Johnsen, K. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60666-2 · Cited by 1
Self-citationGray, A. M., Holman, R. R., Clarke, P., & Leal, J. (2014) · Value in Health · doi:10.1016/j.jval.2014.07.008 · Cited by 1
Tanner, M. (2020) · Annals of Internal Medicine · doi:10.7326/acpj202004210-041 · Cited by 1
Diabetes Screening in Inmates: A Quality Improvement Pilot Project
Castro, M. E. (2014) · OpenCommons at University of Connecticut (University of Connecticut) · Cited by 1
Uncovering Heart Failure in Type 2 Diabetes
Winter, L. J. M. B.-D. (2015) · Utrecht University Repository (Utrecht University) · doi:10.13140/rg.2.1.1508.7448 · Cited by 1
The Epidemiology of Macrovascular Complications of Diabetes in Finland 1992-2002
Winell, K. (2013) · Työväentutkimus Vuosikirja
Oberbauer, R. W. (2012) · Der Nephrologe · doi:10.1007/s11560-012-0640-0
Possible Computer Model for Predicting Cardiovascular Disease in Type 2 Diabetes
Snell‐Bergeon, J. K. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0269
Correspondence: Response to Letter to the Editor by K Scharf and J Morton
Lebovitz, H. E. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1099-4
Cardiovascular Risk in Diabetes Mellitus: Cause and Effect
Pollack, C. V., Ford, W. T., Volturo, G., Badlani, S., Yu, D. J., & Brogan, G. X. (2013) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-013-0034-2
Klinische Merkmale des Typ-2-Diabetes zum Zeitpunkt der Diagnose
Jecht, M. (2013) · Der Diabetologe · doi:10.1007/s11428-013-1076-5
Intensieve behandeling bij DM2
Houweling, B., & van Hateren, H. (2011) · Huisarts en Wetenschap · doi:10.1007/s12445-011-0326-2
How to screen for diabetes risk in multi-ethnic populations: does one method fit all?
Schwarz, P. E. H., & Müller, G. (2013) · European Diabetes Nursing · doi:10.1002/edn.229
Efficient monitoring of type 2 diabetes in primary care
Wermeling, P. R., Health, C., Health, J. O. C., Science, G. P. &. N., Rutten, G. E. H. M., Gorter, K., & Beulens, J. W. J. (2013) · Utrecht University Repository (Utrecht University)
Self-citationPrimär- und Sekundärprävention des Schlaganfalls bei Diabetes
Geisler, F., Endres, M., & Jungehulsing, G. J. (2013) · Der Diabetologe · doi:10.1007/s11428-012-0949-3
Krempf, M., & Charbonnel, B. H. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30263-7
Kan diabetes mellitus type 2 genezen?
Huls, M., van Dijk, M., & Boesten, M. (2015) · TvPO · doi:10.1007/s12503-015-0081-0
Expiration, C., & Singh, S. (2015)
Screening op diabetes: wie, hoe en waarom (niet)?
Woolthuis, E. P. K. (2015) · TvPO · doi:10.1007/s12503-015-0042-7
Screening for type 2 diabetes does not reduce mortality over 10 years
Adriaanse, M. C., & Pouwer, F. (2013) · BMJ Evidence-Based Medicine · doi:10.1136/eb-2012-101186
The long-term benefi ts of lifestyle interventions for prevention of diabetes
Bloomgarden, Z. T. (2014)
Nanosciences, Diabetes and the Patient
Martín, R. G. D. M., Le Mignon, L., Hunter, R. P., Patel, B., & Preedy, R. (2012) · Science Publishers eBooks · doi:10.1201/b11775-25
Clinical perspectives on the management of advanced stable coronary disease
de Silva, R., & Fox, K. M. (2012) · Informa Healthcare eBooks · doi:10.3109/9781841848549.031
The use of glucose measurements to improve screening for diabetes in clinical practice
Nicholls, A. R., Böhning, D., Holt, R. I. G., & Sharp, P. S. (2016) · British Journal of Diabetes · doi:10.15277/bjd.2016.090
Correspondence: Response to Letter to the Editor by K Scharf
Morton, J. I., & Lebovitz, H. E. (2014)
Should the Target A1C Level Be Less Than 7 Percent
Barry, H. C. (2012)
Towards Early Diagnosis and Prevention of Type 2 Diabetes: the Role of Smartphones
Ogeh, D. N., & Fatumo, S. (2014)
Zhuravlyova, L., Sokolnikova, N. V., & Pylov, D. (2016) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2016.02.098
Bakides, S., Nino, K., & Sakellariadis, G. (2017) · Universal Journal of Public Health · doi:10.13189/ujph.2017.050502
Denk tijdig aan metformine bij diabetes
Jans, N. (2017) · Huisarts en Wetenschap · doi:10.1007/s12445-017-0242-1
Intensified Early Treatment of Subclinical Diabetes: No Benefit at 5 Years
Soloway, B. (2011) · Journal watch · doi:10.1056/jw201107120000001
Screening strategies for dysglycaemia in relation to cardiovascular risk
Shahim, B. (2019) · Figshare
Inference on win ratio for clustered semi-competing risk data
Zhang, D. (2019) · D-Scholarship@Pitt (University of Pittsburgh)
Insulin sensitivity is mediated by glucose in the hepatoportal region in the rat
Johnson, H. M. (2017) · The Sydney eScholarship Repository (The University of Sydney)
Xhakaza, L. (2019) · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape)
Gray, L. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-38647-4_5
Chatzikyrkou, C., Scurt, F. G., Menne, J., Korda, A. I., Mertens, P. R., & Haller, H. G. (2020) · Blood Pressure · doi:10.1080/08037051.2020.1750298
Association between Smoking and the Switching to Insulin Therapy in Type 2 Diabetes Patients
Sağlam, Z. A., Saler, T., & Köse, Ş. (2022) · International Journal of Diabetes and Clinical Research · doi:10.23937/2377-3634/1410154
Épidémiologie des états diabétiques
Fontbonne, A. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75889-8.00001-4
Bjerg, L., Laugesen, E., Andersen, S. T., Schaarup, J. R., Charles, M., Vistisen, D., & Witte, D. R. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00890-1
Observational Evaluations of Disease Management Programs for Diabetes: The Proof Is in the Concept
Willey, V. J., & Crowley, M. J. (2022) · Diabetes Care · doi:10.2337/dci22-0030
Personalised and patient-centred diabetes care
den Ouden, H. (2023) · doi:10.33540/1762
Hosoki, M., Hori, T., Kaneko, Y., Mori, K., Yasui, S., Tsuji, S., Yamagami, H., Kawata, S., Hara, T., Masuda, S., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051283
Hoe behandel je mensen met type 2-diabetes in remissie?
Holtrop, R. (2024) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-024-1557-8
Dede, B., & Eser, E. (2024) · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi · doi:10.47572/muskutd.1444546
Bioinformatics on Screening and Pathway Analysis of Early Diabetic Nephropathy Related Genes
Sang, Y. (2024) · Transactions on Materials Biotechnology and Life Sciences · doi:10.62051/s0fd6k65
Andersen, J. W., Høgh, A. L., Lindholt, J. S., Søgaard, R., Støvring, H., Yderstræde, K. B., Sandbæk, A., & Dahl, M. (2025) · Clinical Epidemiology · doi:10.2147/clep.s487825
Self-citationYang, J., Zhang, R., Han, B., Li, H., Wang, J., Xiao, Y., Yu, X., Guan, S., Dai, C., Yan, H., et al. (2025) · Global Heart · doi:10.5334/gh.1400 · Cited by 1
Ahmed, T. (2025) · Springer eBooks · doi:10.1007/978-981-96-2120-0_7
Prevalence of Diabetes Among U.S. Refugees and Opportunities to Improve Screening, 2012–2022
Kollannoor-Samuel, G., Settgast, A. M., Walker, P. F., Chrenka, E. A. B., Steiner, A. S., Payton, C., Frumholtz, M., Rodrigues, K. K., Bergenstal, R. M., & DeSilva, M. B. (2025) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-025-01706-w
Wang, K., Wei, C., & Labrecque, J. A. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-109205 · Cited by 1
Fukaguchi, K., Shinozaki, T., Narita, Z. C., & Goto, A. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113020
Ekström, N. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Frison, É. (2019) · theses.fr (ABES) · doi:10.70675/a527bd03zb814z44e5z8848z942b662a0847
Banerjee, D., Seki, A., Watanabe, K., & Nishiyama, M. (2026) · IEEE Sensors Journal · doi:10.1109/jsen.2026.3685587
Sreedevi, A., Janakiram, C., Sasidharan, N., Menon, V. B., Divya, C. S., Nair, V. G., Aravind, M. S., Gopal, B. K., Numpeli, M., Krishnan, A., et al. (2026) · Trials · doi:10.1186/s13063-026-09793-2
Screening for undiagnosed hyperglycemia in patients with periodontitis: a cross-sectional study
Gouveia, F. N. A., Galvão, P. E. B. D. S., Silva, A. R. B. E., da Figueira, M. A. S., Ribeiro, J. B. J., de Molon, R. S., Fogacci, M. F., & Barbirato, D. D. S. (2026) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2026ao2397
Kim, S. H., Arora, I., Agyemang, C. O., Anjana, R. M., Åsvold, B. O., Blom, M. T., Bhupathiraju, S. N., Bonnefond, A., Chan, J. C. N., Davis, T. M. E., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06812-4
Yang, Q., Lyu, Z., Liu, M., Gao, F., meng, Y., Gong, Y., He, X., & Ge, W. (2026) · Research Square · doi:10.21203/rs.3.rs-10700011/v1
Diabetes and the role of primary care: a global perspective
Kar, P. S., Sathanapally, H., Aschner, P. J., Baatiema, L., Cheng, A., Gupta, Y., Hambling, C. E., Ma, R., Seidu, S., & Khunti, K. K. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00214-7
Self-citation
Metadata
- Authors
- Griffin, S. J., Borch-Johnsen, K., Davies, M. J., Khunti, K., Rutten, G. E., Sandbæk, A., Sharp, S. J., Simmons, R. K., van den Donk, M., Wareham, N. J., & Lauritzen, T.
- Affiliations
- University of Cambridge (GB)
- University of Leicester (GB)
- University Medical Center Utrecht (NL)
- Aarhus University (DK)
- Wellcome/MRC Institute of Metabolic Science (GB)
- Corresponding author
- Griffin, Simon J
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 378
- Issue
- 9786
- Pages
- 156-167
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC3136726
- OpenAlex
- W2146392529
- Cited by
- 462
- References
- 43
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 17 · 2023: 14 · 2022: 21 · 2021: 18 · 2020: 35 · 2019: 31 · 2018: 30 · 2017: 38 · 2016: 30 · 2015: 49 · 2014: 46 · 2013: 46 · 2012: 56
- FWCI
- 50.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Funders
- the Wellcome Trust (G061895)
- the Medical Research Council (G0001164)
- the NIHR Health Technology Assessment Programme (08/116/300)
- National Health Service R&D support funding (RP-PG-0606-1259)
- Department of Health and ad hoc Support Sciences, the NIHR Health Technology Assessment Programme (08/116/300)
- the Department of Health NIHR Programme Grant funding scheme (RP-PG-0606-1272)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, cardiovascular risk management, diabetes screening, cardiovascular events, cardiovascular mortality, all-cause mortality, revascularization, non-traumatic amputation, HbA1c, blood pressure, cholesterol, general practice, primary prevention, secondary prevention, risk stratification
- MeSH terms
- Aged, Denmark, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Mass Screening, Middle Aged, Netherlands, Risk Factors, Cluster Analysis, Outcome Assessment, Health Care, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
